glp-1 drugs and depression The risk of depression, anxiety, suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy GLP-1 Drug Improved Motivation in
Description
References Istituto Superiore di Sanit (2021) Dati Sorveglianza PASSI 20202021
A.HammoudR.RittigN.et al (2024)
The study, published in the Journal of General Internal Medicine, is the first to examine semaglutides effectiveness specifically in a Department of Veterans Affairs weight management program rather than in a pharmaceutical companys clinical trial
Additionally, we manually searched the websites of the European Association for the Study of Diabetes and American Diabetes Association scientific meetings, as well as ClinicalTrials.gov, to retrieve additional qualified trials or search the database for any additional information on trials that have been identified
The products sold under the "GLP-1 patch" label on Amazon, TikTok, and brand websites contain herbal ingredients, not GLP-1 drugs
